Kaupinen Wes 13D and 13G filings for Palvella Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-20 5:32 pm Purchase | 2024-12-13 | 13D | Palvella Therapeutics, Inc. PVLA | Kaupinen Wes | 1,644,869 14.600% | 1,644,869 (New Position) | Filing |